Home » Topics » BioWorld Science

BioWorld Science
RSS

Neuropathy may unify disparate long COVID symptoms

March 2, 2022

HuR ablation ameliorates allergen-induced asthmatic symptoms

March 2, 2022

LIGHT mediates esophageal remodeling in murine model of eosinophilic esophagitis

March 2, 2022

Quanterix collaborates with Lilly on diagnosis and treatment of Alzheimer's disease

March 2, 2022

JAK1 activation of sensory neurons suppresses lung inflammation

March 2, 2022

HLA-DPB1*05:01 allele predicts nonresponse to SLIT in allergic rhinitis

March 2, 2022

SIGLEC-6 targeting inhibits human mast cell degranulation and anaphylaxis

March 2, 2022

Bayer, Deutsches Krebsforschungszentrum patent aryl hydrocarbon receptor antagonists

March 2, 2022

Complement factor B inhibitors discovered at Shanghai Meiyue Biotech Development

March 2, 2022

Spexis, University of Zurich describe new antimicrobial peptidomimetics

March 2, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...